High percentage of Hepatitis C patients take herbs and vitamins, according to Rush survey

A survey conducted by Rush-Presbyterian-St. Luke's Medical Center found that 87 percent of Hepatitis C patients are currently taking vitamins, herbal preparations or both.

"Use of alternative therapies is increasing in the United States and many patients with chronic liver disease may use herbal and over the counter medications believing that these are harmless and potentially beneficial," said Dr. Donald Jensen, director of the section of hepatology, Rush-Presbyterian-St. Luke's Medical Center.

However, there is little information on the safety and almost none on the efficacy of these medications with an existing health population, and less still in a patient population with chronic Hepatitis C, he added.

Hepatitis C is a virus that people contract through blood transfusions or sexual contact. There are approximately 3.9 million Americans with Hepatitis C and 36,000 new cases are diagnosed each year. Patients are treated with antiviral therapy, which has been found to be effective in 10 to 40 percent of patients.

Jensen and other Rush hepatologists noticed patients were taking these therapies and were concerned about the medication's effect on their health and on the clinical trials

Rush is conducting. "It is not known what effect, if any, these therapies have on the data that comes from clinical trials," he said. "This is the first step toward understanding the role alternative therapies play in Hepatitis C treatment." The patients surveyed were undergoing treatment with antiviral therapy for their condition.

In response, Rush asked 60 patients between April and June 1999 about their use of alternative therapies. Half of those patients indicated they take vitamins or minerals, with 55 percent reporting regular use of folic acid, 52 percent taking multivitamins, 28 percent using vitamin E, 23 percent taking vitamin C and 20 percent on calcium.

Forty percent

Contact: Chris Martin
Rush University Medical Center

Page: 1 2

Related biology news :

1. New study: percentage of babies born with intestinal birth defect growing in U.S., N.C.
2. Benzene responsible for high percentage of leukemia deaths induced by smoking
3. Risk of Hepatitis E from consumption of deer?
4. Hepatitis C infection does not alter HIV progression or treatment
5. Need, potential for Hepatitis C vaccine highlighted by Hopkins study
6. Hepatitis E recovered from rats in Los Angeles
7. Hepatitis C drug overwhelms virus with flood of mutations - surprising mechanism may improve anti-viral treatments, UCSF study finds
8. Explaining the persistence of Hepatitis C
9. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory
10. Hepatitis E virus infection may be widespread in rats
11. Hepatitis C is not a silent disease

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: